Tianlong Lan
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- PARP inhibition in cancer therapy
Papers in
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 2
- Histone Deacetylase Inhibitors Research 2
- CRISPR and Genetic Engineering 2
- Epigenetics and DNA Methylation 1
-
- Catalytic C–H Functionalization Methods 2
- Synthesis and Catalytic Reactions 2
- Co-authors
- Yu Rao (8 shared papers)Qiuye Zhao (2 shared papers)Shang Su (1 shared paper)Liguo Wang (2 shared papers)Xiuyun Sun (3 shared papers)Hongying Gao (2 shared papers)Xinyi Zhang (1 shared paper)Jianguo Zhao (1 shared paper)
In The Last Decade
Tianlong Lan
9 papers receiving 519 citations
Peers
Comparison fields: 5 of 68
- Hematology 81
- Oncology 160
- Drug Discovery 1
- Molecular Biology 321
- Organic Chemistry 134
Countries citing papers authored by Tianlong Lan
This map shows the geographic impact of Tianlong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianlong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianlong Lan more than expected).
Fields of papers citing papers by Tianlong Lan
This network shows the impact of papers produced by Tianlong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianlong Lan. The network helps show where Tianlong Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Tianlong Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 140 | |
| 2 | 2021 | 107 | |
| 3 | 2019 | 88 | |
| 4 | 2017 | 68 | |
| 5 | 2019 | 52 | |
| 6 | 2015 | 37 | |
| 7 | 2021 | 25 | |
| 8 | 2024 | 9 | |
| 9 | 2021 | 1 |
About Tianlong Lan
Tianlong Lan is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Infectious Diseases and Hematology, having authored 9 papers that have together received 527 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Ubiquitin and proteasome pathways (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Catalytic C–H Functionalization Methods (2 papers), CRISPR and Genetic Engineering (2 papers), Synthesis and Catalytic Reactions (2 papers), PARP inhibition in cancer therapy (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Hematology (81 citations), Oncology (160 citations), Drug Discovery (1 citation), Molecular Biology (321 citations) and Organic Chemistry (134 citations). Tianlong Lan has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Yu Rao, Qiuye Zhao, Shang Su, Liguo Wang, Xiuyun Sun, Hongying Gao, Xinyi Zhang, Jianguo Zhao, Yonghui Sun and Xiuqin Zhang. Their work appears in journals such as Chemical Communications, Journal of Medicinal Chemistry, Nature Chemical Biology, RSC Advances and Organic Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.